Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research Into the Effect of SGLT2 Inhibition on Left Ventricular Remodeling in Patients With Heart Failure and Diabetes Mellitus

Trial Profile

Research Into the Effect of SGLT2 Inhibition on Left Ventricular Remodeling in Patients With Heart Failure and Diabetes Mellitus

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2018

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Chronic heart failure; Heart failure; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms REFORM; The REFORM Trial
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 26 Jul 2018 New source identified and integrated. (European Clinical Trials Database; EudraCT2014-002742-42)
    • 26 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top